All sponsors

Suzhou Alphamab Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING2
READOUTS ≤12 MONTHS1
READOUT SLIPPED >6 MO0%

Delay Index: of 5 active trials registered more than a year ago, 0 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Suzhou Alphamab Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
KN057
NCT06312475
P3Active, not recruitingHemophilia A With Inhibitor; Hemophilia B With Inhibitor532025-10-15
Enoxaparin
NCT06180889
P2Active, not recruitingKnee Arthroplasty, Total2412025-12-15
KN057
NCT06747416
P2Not yet recruitingHemophilia a and B242026-09-02
KN057
NCT06569108
P3Active, not recruitingHemophilia A Without Inhibitor; Hemophilia B Without Inhibitor1252026-10-15
KN060
NCT07201467
P1/2RecruitingEnd-Stage Renal Disease Requiring Haemodialysis122027-08-15
KN057
NCT07545395
P3RecruitingHemophilia A or B702027-12-30